Clinical trial
Immunogenicity of COVID-19 Vaccines in MS Patients on B-cell Depleting Therapy
NCT05121662 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity of COVID-19 Vaccines in MS Patients on B-cell Depleting Therapy
- Lead sponsor
- Columbia University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 29, 2021
- Completion date
- February 13, 2025
- Enrollment
- 154 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.